Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation
Author(s) -
Maria Embgenbroich,
Hendrik J.P. van der Zande,
Leonie Hussaarts,
Jonas Schulte-Schrepping,
Leonard R. Pelgrom,
Noemí GarcíaTardón,
Laura Schlautmann,
Isabel Stoetzel,
Kristian Händler,
Joost M. Lambooij,
Anna ZawistowskaDeniziak,
Lisa R. Hoving,
Karin de Ruiter,
Marjolein A. Wijngaarden,
Hanno Pijl,
Ko Willems van Dijk,
Bart Everts,
Vanessa van Harmelen,
Maria Yazdanbakhsh,
Joachim L. Schultze,
Bruno Guigas,
Sven Burgdorf
Publication year - 2021
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2103304118
Subject(s) - proinflammatory cytokine , macrophage , regulator , mannose receptor , receptor , downregulation and upregulation , homeostasis , immunology , inflammation , chemistry , microbiology and biotechnology , medicine , biology , biochemistry , in vitro , gene
Significance Obesity-associated metaflammation is an emerging disease, in which proinflammatory macrophages play a decisive role. Here, we identified the soluble mannose receptor (sMR) as a regulator of metaflammation and demonstrated increased levels of sMR in obese mice and humans. Additionally, we identified that increased sMR directly binds to CD45 on macrophages, inhibiting its activity and inducing inflammatory macrophage activation via the Akt/NF-κB pathway. Consequently, increased sMR levels induced inflammatory activation of metabolic tissue macrophages and aggravation of whole-body metabolic homeostasis. These data identify the MR as a regulator of macrophage activation and offer perspectives for therapeutic approaches for the treatment of metaflammation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom